1 / 38

Efficacy of Natalizumab in Crohn s Disease

Natalizumab for the Treatment of Crohn's Disease. Mechanism of action of natalizumabTreatment objectives for Crohn's disease, and the clinical trial tools used to evaluate themEfficacy of natalizumab in the Phase III clinical development program Induction of response (CD301, CD307) Maintenance o

tex
Télécharger la présentation

Efficacy of Natalizumab in Crohn s Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Efficacy of Natalizumab in Crohn’s Disease Stephen Jones, MBBS Director, Clinical Development

    2. Natalizumab for the Treatment of Crohn’s Disease Mechanism of action of natalizumab Treatment objectives for Crohn’s disease, and the clinical trial tools used to evaluate them Efficacy of natalizumab in the Phase III clinical development program Induction of response (CD301, CD307) Maintenance of response (CD303) Summary of Efficacy

    3. Integrins Mediate Leukocyte Adhesion During Inflammation

More Related